Articles by : Rich Daly, Editor in Chief

Federal Government Passes on Appealing Key Patient Definition Ruling

January 5, 2024 Rich Daly, Editor in Chief Views

Genesis Health care facility and signage

The Biden administration will not appeal a high-profile November federal court ruling on the 340B patient definition.

The Biden administration will not appeal a high-profile November federal court ruling to prohibit enforcement of a 340B patient definition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two 340B Terminations, Two Paybacks to Manufacturers in Latest Provider Audit Findings

January 5, 2024 Rich Daly, Editor in Chief Views

Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of two more 340B providers.

Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk, Arkansas Reach Temporary Deal Amid Contract Pharmacy Fight

January 4, 2024 Rich Daly, Editor in Chief Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

Novo Nordisk will lift restrictions in Arkansas on 340B providers’ contract pharmacy arrangements and Arkansas will suspend enforcement against the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Gilead Expands 340B Reporting to Wholly Owned Contract Pharmacies

January 3, 2024 Rich Daly, Editor in Chief Views

Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies wholly owned by covered entities.

Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Offers Refunds on Blockbuster Drug, Other Manufacturers Update NDCs

January 3, 2024 Rich Daly, Editor in Chief Views

Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.

Drugmaker Johnson & Johnson will offer refunds to 340B providers related to the purchases of four of its drugs, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Critics of 340B Urge Congressional Reforms of the Program

December 21, 2023 Rich Daly, Editor in Chief Views

Edolphus Towns, Jr., a former congressman (D-N.Y.) who voted to create the 340B program, recently wrote a guest editorial calling for congressional reforms.

Critics of the 340B program, including a former congressman who voted to create the program, have written recent editorials urging [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

December 19, 2023 Rich Daly, Editor in Chief Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Defers Decision on Adding 340B Modifiers for Part D Drugs

December 19, 2023 Rich Daly, Editor in Chief Views

In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.

Federal regulators recently deferred a decision on whether to add identifiers to 340B drugs purchased under Medicare Part D. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

December 14, 2023 Rich Daly, Editor in Chief Views

HRSA released a new web page with resources on the agency's 340B program patient definition and compliance guidelines.

In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Articles by : Rich Daly, Editor in Chief

Federal Government Passes on Appealing Key Patient Definition Ruling

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Two 340B Terminations, Two Paybacks to Manufacturers in Latest Provider Audit Findings

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Top 10 Most Read 340B Report Articles in 2023

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Novo Nordisk, Arkansas Reach Temporary Deal Amid Contract Pharmacy Fight

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Gilead Expands 340B Reporting to Wholly Owned Contract Pharmacies

Please Login or Become a Paid Subscriber to View this Content

If you are already a

J&J Offers Refunds on Blockbuster Drug, Other Manufacturers Update NDCs

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Critics of 340B Urge Congressional Reforms of the Program

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

Please Login or Become a Paid Subscriber to View this Content

If you are already a

CMS Defers Decision on Adding 340B Modifiers for Part D Drugs

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live